| 0.8599 -0.025 (-2.84%) | 08-21 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.23 | 1-year : | 1.37 |
| Resists | First : | 1.05 | Second : | 1.17 |
| Pivot price | 0.99 |
|||
| Supports | First : | 0.85 | Second : | 0.7 |
| MAs | MA(5) : | 0.89 |
MA(20) : | 0.97 |
| MA(100) : | 1.57 |
MA(250) : | 2.58 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 7.1 |
D(3) : | 10.2 |
| RSI | RSI(14): 36.6 |
|||
| 52-week | High : | 4.7 | Low : | 0.73 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NNOX ] has closed above bottom band by 6.5%. Bollinger Bands are 47.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.92 - 0.93 | 0.93 - 0.93 |
| Low: | 0.84 - 0.85 | 0.85 - 0.85 |
| Close: | 0.85 - 0.86 | 0.86 - 0.87 |
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Sat, 22 Aug 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX - Eastern Progress
Fri, 21 Aug 2026
NNOX News | NANO-X IMAGING LTD (NASDAQ:NNOX) - ChartMill
Tue, 18 Aug 2026
Nanox and Vertec Scientific Enter Exclusive Sales Reseller - GlobeNewswire
Tue, 18 Aug 2026
Nano-X (NASDAQ: NNOX) warns on cash runway before vote to boost share pool - Stock Titan
Tue, 11 Aug 2026
NNOX Deadline Alert: SueWallSt Reminds Nano-X Imaging Ltd. (NNOX) Investors of Securities Class Action Deadline on August 11, 2026 - PR Newswire
Thu, 06 Aug 2026
Nano-X sets $1 combined price for shares and accompanying warrants - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 70 (M) |
| Shares Float | 64 (M) |
| Held by Insiders | 7.5 (%) |
| Held by Institutions | 18.3 (%) |
| Shares Short | 7,200 (K) |
| Shares Short P.Month | 8,550 (K) |
| EPS | -1.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.82 |
| Profit Margin | 0 % |
| Operating Margin | -337.1 % |
| Return on Assets (ttm) | -22.3 % |
| Return on Equity (ttm) | -50.2 % |
| Qtrly Rev. Growth | 53 % |
| Gross Profit (p.s.) | -0.18 |
| Sales Per Share | 0.2 |
| EBITDA (p.s.) | -0.72 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -44 (M) |
| Levered Free Cash Flow | -29 (M) |
| PE Ratio | -0.75 |
| PEG Ratio | 0 |
| Price to Book value | 0.47 |
| Price to Sales | 4.12 |
| Price to Cash Flow | -1.35 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|